ACHP Letter to CMS on CY 2025 MA and Part D Advance Notice
ACHP submitted comments to CMS on the CY 2025 Medicare Advantage and Part D Advance Notice, commending the Administration’s efforts to improve the MA program.
ACHP submitted comments to CMS on the CY 2025 Medicare Advantage and Part D Advance Notice, commending the Administration’s efforts to improve the MA program.
ACHP issued a statement in response to CMS’ CY 2025 Advance Notice for Medicare Advantage and Part D.
ACHP submitted comments to CMS to support enhanced consumer experience and greater efficiency in the marketplace in response to the proposed 2025 Notice of Benefit and Payment Parameters.
ACHP strongly supports CMS’ proposed CY 2025 Medicare C & D rule, which supports consumer choice and caps broker compensation.
ACHP supports CMS’ proposals to reform broker agent compensation and urges immediate implementation to support and improve the Medicare Advantage and Part D programs.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.